Back to results

Alma Mater Studiorum - Università di Bologna

Development of screening assays to test novel integrin antagonists in allergic inflammation

Abstract

dc:description

Aim of the research: to develop a prototype of homogeneous high-throughput screening (HTS) for identification of novel integrin antagonists for the treatment of ocular allergy and to better understand the mechanisms of action of integrin-mediated levocabastine antiallergic action. Results: This thesis provides evidence that adopting scintillation proximity assay (SPA) levocabastine (IC50=406 mM), but not the first-generation antihistamine chlorpheniramine, displaces [125I]fibronectin (FN) binding to human a4b1 integrin. This result is supported by flow cytometry analysis, where levocabastine antagonizes the binding of a primary antibody to integrin a4 expressed in Jurkat E6.1 cells. Levocabastine, but not chlorpheniramine, binds to a4b1 integrin and prevents eosinophil adhesion to VCAM-1, FN or human umbilical vein endothelial cells (HUVEC) cultured in vitro. Similarly, levocabastine affects aLb2/ICAM-1-mediated adhesion of Jurkat E6.1 cells. Analyzing the supernatant of TNF-a-treated (24h) eosinophilic cells (EoL-1), we report that levocabastine reduces the TNF-a-induced release of the cytokines IL-12p40, IL-8 and VEGF. Finally, in a model of allergic conjunctivitis, levocastine eye drops (0.05%) reduced the clinical aspects of the early and late phase reactions and the conjunctival expression of a4b1 integrin by reducing infiltrated eosinophils. Conclusions: SPA is a highly efficient, amenable to automation and robust binding assay to screen novel integrin antagonists in a HTS setting. We propose that blockade of integrinmediated cell adhesion might be a target of the anti-allergic action of levocabastine and may play a role in preventing eosinophil adhesion and infiltration in allergic conjunctivitis.

Degree

thesis:*
Grantor dc:publisher
Alma Mater Studiorum - Università di Bologna
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Spartà, Antonino Maria <1977>
Contributors dc:contributor
  • Spampinato, Santi Mario

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
en

Identifiers

dc:identifier.*
Identifier
urn:nbn:it:unibo-1363
OAI identifier oai:identifier
oai:amsdottorato.cib.unibo.it:1613

Chain of custody

source
Harvested from
Università di Bologna
Base URL
amsdottorato.unibo.it/cgi/oai2
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Spartà, Antonino Maria <1977>. Development of screening assays to test novel integrin antagonists in allergic inflammation. Alma Mater Studiorum - Università di Bologna, 2009. https://doi.org/10.6092/unibo/amsdottorato/1613.